Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.8B | 2.6B | 3.0B | 3.1B |
Cost of revenue | 1.5B | 1.3B | 1.4B | 1.6B |
Gross profit | 1.3B | 1.3B | 1.6B | 1.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 636.8M | 614.4M | 717.2M | 638.1M |
Operating income | 405.8M | 415.3M | 563.6M | 617.4M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 11.3M | 1.6M | 6.7M | 4.2M |
Other income expense | — | — | — | — |
Pretax income | 493.3M | 266.3M | 651.4M | 665.9M |
Tax provision | -53.1M | 64.4M | 158.8M | 166.8M |
Net income | 546.4M | 201.9M | 492.6M | 499.1M |
Basic EPS | — | 7.4 | 18.1 | 18.3 |
Diluted EPS | — | 7.4 | 18.1 | 18.3 |
Basic average shares | — | 27.2M | 27.2M | 27.2M |
Diluted average shares | — | 27.2M | 27.2M | 27.2M |
EBITDA | 621.0M | 551.1M | 754.7M | 764.1M |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |